Mr
Douglas
Drysdale

Partner & Patent Attorney

Glasgow Office

Life sciences

Telephone. +44(0) 141 229 5800
Mobile. +44(0) 783 322 8216
Email. [email protected]

Experience

Douglas specialises in global patent strategy, filing and prosecution, advising a wide range of clients on how to build and maximise the value of their IP estate. He is also extremely experienced in patent opposition and appeals, regularly representing his clients in high profile hearings at the EPO. Douglas and his team represent leading biotech and life science companies, as well as several universities. His clients appreciate his desire to understand both their business and their technology.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

Molecular Biology - 1st Class Honours

MSC

MSc - Management of IP Law - Queen Mary's University of London

Publications

IAM Strategy 300 2021

View publication online

G1/21 hearing at the EPO

View publication online

T0694/16 - New EPO Technical Board of Appeal decision regarding personalised healthcare inventions

View publication online

Conferences: 2021

July 2nd 2021

G1/21 hearing at the EPO - July

Attended

Event details

Conferences: 2020

January 28th 2020

IAM Pharma & Biotech IP Summit 2020 - London

Speaker

Event details

Related News

Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Healthcare and Climate Change

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis? “The world faces a critical juncture. A health-centred, aligned response to the …

Read article

Navigating the CRISPR IP confusion

It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 …

Read article

CRISPR Edited T cells win the TvT Battle

T-cells which have been modified using CRISPR base editing technology have been successfully used to treat T-cell acute lymphoblastic leukaemia for the first time {1}. A 13 year old patient …

Read article

Dot Inc, the accessible future and more: health tech highlights coming to CES 2023

The countdown is on for CES 2023. Taking place in Las Vegas in the first week of January each year, CES sets the global stage for innovation in the tech …

Read article

Can AI replace patent attorneys?

OpenAI recently released a dialogue-based AI chatbot called ChatGPT, which is free for anyone to try out. You can try it here (https://chat.openai.com/chat). It’s been shown that it can set, …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.